Danske Bank A S Acquires 683,382 Shares of Align Technology, Inc. $ALGN

Danske Bank A S increased its holdings in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 1,366,764.0% during the third quarter, HoldingsChannel.com reports. The fund owned 683,432 shares of the medical equipment provider’s stock after buying an additional 683,382 shares during the period. Danske Bank A S’s holdings in Align Technology were worth $90,426,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in Align Technology during the 2nd quarter worth $745,370,000. Assenagon Asset Management S.A. grew its position in Align Technology by 638.7% during the 3rd quarter. Assenagon Asset Management S.A. now owns 4,662,437 shares of the medical equipment provider’s stock worth $629,469,000 after purchasing an additional 4,031,284 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA increased its stake in Align Technology by 3,162.7% in the third quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,097,745 shares of the medical equipment provider’s stock valued at $278,342,000 after purchasing an additional 2,033,451 shares during the period. Vontobel Holding Ltd. increased its stake in Align Technology by 69,628.9% in the third quarter. Vontobel Holding Ltd. now owns 1,385,513 shares of the medical equipment provider’s stock valued at $183,335,000 after purchasing an additional 1,383,526 shares during the period. Finally, Retirement Systems of Alabama increased its stake in Align Technology by 4,748.6% in the third quarter. Retirement Systems of Alabama now owns 678,422 shares of the medical equipment provider’s stock valued at $89,943,000 after purchasing an additional 664,430 shares during the period. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on ALGN shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Align Technology in a report on Thursday, October 29th. Mizuho decreased their target price on shares of Align Technology from $220.00 to $200.00 and set an “outperform” rating for the company in a research note on Thursday, October 22nd. Stifel Nicolaus reduced their price objective on Align Technology from $210.00 to $175.00 and set a “buy” rating for the company in a research note on Friday, October 9th. Morgan Stanley reduced their price objective on Align Technology from $188.00 to $175.00 and set an “equal weight” rating for the company in a research note on Thursday, October 29th. Finally, Wall Street Zen cut Align Technology from a “buy” rating to a “hold” rating in a research report on Saturday, October 24th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $193.08.

View Our Latest Research Report on ALGN

Align Technology Price Performance

Shares of ALGN stock traded up $1.35 during midday trading on Friday, reaching $168.32. 665,625 shares of the company traded hands, compared to its average volume of 1,198,686. The firm’s 50 day simple moving average is $151.67 and its two-hundred day simple moving average is $168.57. Align Technology, Inc. has a 1-year low of $130.23 and a 1-year high of $200.43. The firm has a market cap of $11.86 billion, a PE ratio of 24.50, a price-to-earnings-growth ratio of 2.16 and a beta of 1.74.

Align Technology (NASDAQ:ALGN – Get Free Report) last released its quarterly earnings results on Wednesday, October 28th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping analysts’ consensus estimates of $2.77 by $0.03. The business had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1 billion. Align Technology had a return on equity of 15.96% and a net margin of 11.83%. The company’s revenue was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.61 EPS. As a group, research analysts anticipate that Align Technology, Inc. will post 9.21 earnings per share for the current fiscal year.

About Align Technology

(Free Report)

Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.

See Also

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.